Table 2. Average monthly prevalence of pyoderma and scabies, EAHSP, September 2004–August 2007.
| Sep04–Feb06 (18 months) % (95%CI) | Mar06–Aug07 (18 months) % (95%CI) | Absolute difference % (95%CI) | p | |
| Pyoderma | ||||
| All ages | 46.0 (44.1,48.0) | 27.5 (26.0,29.0) | −18.5 (−21.0,−16.1) | <0.001 |
| Aged <3 yrs | 41.7 (37.7,45.8) | 30.0 (26.4,33.6) | −11.8 (−17.2,−6.3) | <0.001 |
| Aged 3-<9 yrs | 51.1 (48.4,53.9) | 31.6 (29.4,33.8) | −19.5 (−23.1,−16.0) | <0.001 |
| Aged 9–14 yrs incl | 41.3 (37.9,44.7) | 19.7 (17.4,22.1) | −21.6 (−25.7,−17.5) | <0.001 |
| Additional data * | ||||
| Upper body pyoderma * | 22.7 (19.8,25.6) | 13.5 (11.4,15.6) | −9.2 (−12.8,−5.7) | <0.001 |
| Lower body pyoderma * | 44.1 (40.7,47.5) | 30.4 (27.6,33.2) | −13.7 (−18.1,−9.3) | <0.001 |
| Upper body 5 or more sores | 5.2 (3.6,6.7) | 4.0 (2.8,5.2) | −1.2 (−3.2,0.7) | 0.2 |
| Lower body 5 or more sores | 17.8 (15.1,20.5) | 11.5 (9.5,13.5) | 6.3 (−9.6,−2.9) | <0.001 |
| 5 or more sores * | 19.9 (17.2,22.7) | 12.6 (10.6,14.7) | −7.3 (−3.9,−10.8) | <0.001 |
| Treatment for those with 5+ sores * | 3.8 (−0.4, 7.9) | 17.2 (8.0,26.4) | 13.4 (3.3,23.6) | 0.007 |
| Crusted/purulent pyoderma * | 31.6 (28.4,35.8) | 21.6 (19.0,24.1) | −10.0 (−14.1,−6.0) | <0.001 |
| Treatment for crusted/purulent pyoderma * | 3.9 (1.5,6.2) | 7.3 (3.9,10.8) | 3.5 (−0.7,7.6) | 0.1 |
| Scabies | ||||
| All ages | 14.3 (13.0,15.7) | 12.7 (11.6,13.8) | −1.7 (−3.4,0.1) | 0.06 |
| Aged <3 yrs | 22.6 (19.2,26.0) | 22.8 (19.5,26.1) | 0.2 (−4.5,5.0) | 0.9 |
| Aged 3-<9 yrs | 13.7 (11.8,15.7) | 13.0 (11.4,14.6) | −0.7 (−3.2,1.8) | 0.6 |
| Aged 9–14 yrs incl | 9.4 (7.4,11.4) | 6.3 (4.9,7.8) | −3.1 (−5.5,−0.6) | 0.01 |
| Additional data * | ||||
| Infected scabies* | 3.7 (2.4,4.9) | 1.5 (0.7,2.2) | −2.2 (−3.7,−0.7) | 0.003 |
Notes: “Absolute difference” refers to the difference in the average monthly prevalence in the first 18 months (Sep04–Feb06) compared to the second 18 months (Mar06–Aug07).
*: indicates parameters for which comparable data were sought on 2001 children seen during school screening (age 3–14 years).